Glow-in-the-Dark clip could make colon cancer surgery safer

NCT ID NCT06714292

Completed Disease control Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests a new fluorescent clip that glows under special light to help surgeons locate colon tumors during minimally invasive surgery. About 110 adults with colon cancer will be randomly assigned to receive either the clip or a standard dye injection before surgery. The goal is to see if the clip is as good or better at pinpointing the tumor, with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fluorescent surgical marker clip
What this could lead to: If successful, this clip could provide a more precise and safer way for surgeons to locate colon tumors during minimally invasive surgery, potentially reducing complications.
What could go wrong: This is a Phase 2 trial with only 110 participants, so results are preliminary. The clip may not be more effective than the current dye method, and there are risks like allergic reactions or inaccurate placement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colon carcinoma colonic neoplasm colorectal cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLON CANCER

Contacts and locations

Locations

National Cancer Center

Goyang-si, Gyeonggi-do, 10408, South Korea
Seoul Boramae Medical Center

Seoul, 07061, South Korea
Seoul National University Hospital

Seoul, 03080, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.